Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07641179 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate MAR002 for Acromegaly

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Aug 2026 to Jul 23, 2026v4
  2. Recruitment opened
    • Trial sites expanded: 0 → 3 locations
    • Start date: Jul 2026 to Aug 2026
    v3
  3. Secondary endpoints: 3 to 4v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in participants with acromegaly
Trial Details
NCT Number NCT07641179
Lead Sponsor Marea Therapeutics
Conditions
(from sponsor)		 Acromegaly
Related terms Acromegaly
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov